Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-016849-25Phase 3Terminated
Phase 3, randomised, double-blind trial of pregabalin in Focal onset seizure and epilepsy, sponsored by Pfizer. Started Jan 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-016849-25.